Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy

Rheumatic Disease Clinics of North America

Volumn 26, Issue 4, 2000, Pages 805-823

  Kanik, Keith S ^a   Wilder, Ronald L ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BROMOCRIPTINE; CORTICOTROPIN; ESTROGEN; GLUCOCORTICOID; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PROGESTERONE; PROLACTIN; QUINAGOLIDE; TESTOSTERONE;

BREAST FEEDING; CLINICAL TRIAL; CORTICOSTEROID THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; META ANALYSIS; NULLIPARA; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0033773127     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70170-8     Document Type: Article

References (156)

1. Increased plasma concentration of N-terminal beta-lipotrophin and unbound cortisol during pregnancy
2. Do oral contraceptives reduce the incidence of rheumatoid arthritis? A pilot study using the Stockholm County medical information system
3. Breast stimulation in cycling women, pregnant women and a woman with induced lactation: Pattern of release of oxytocin, prolactin and luteinizing hormone
4. Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women
5. Hormonal pattern of adolescent menstrual cycles
6. Circulating levels of cytokines and cytokine receptors in normal human pregnancy
7. Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns
8. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy
9. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis
10. Forty cases of arthritis and pregnancy
11. Can we use steroid hormones to immunomodulate rheumatic diseases? Rheumatoid arthritis as an example
12. Estrogens and rheumatoid arthritis
13. Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis
14. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women
15. The use of norethynodrel in the treatment of rheumatoid arthritis
16. Influence of the menstrual cycle on systemic diseases
17. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis
18. Breast-feeding and the onset of rheumatoid arthritis
19. Role of androgens in the aetiology of rheumatoid arthritis
20. Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study
21. Rheumatoid arthritis and pregnancy
22. Effects of the menstrual cycle on medical disorders
23. Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone
24. Immune suppression and Th1/Th2 balance in pregnancy revisited: A (very) personal tribute to Tom Wegmann
25. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis
26. Interactions between the hypothalamic-pituitaryadrenal axis and the female reproductive system: Clinical implications
27. The beneficial effects of intra-articular corticosteroids are persistent at 12 months: An MRI study in early rheumatoid arthritis
28. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL- 6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis
29. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis
30. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis
31. Androgen replacement therapy in male patients with rheumatoid arthritis
32. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids
33. Sex hormone status in women suffering from rheumatoid arthritis
34. Comparison of effects of long-term corticotrophin and corticosteroid treatment on responses of plasma growth hormone, ACTH, and corticosteroid to hypoglycaemia
35. The role of pregnancy in the course and aetiology of rheumatoid arthritis
36. A controlled investigation into the aetiology and clinical features of rheumatoid arthritis
37. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative
38. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs
39. Do oral contraceptives prevent rheumatoid arthritis?
40. Rheumatoid arthritis treated by norethynodrel associated with mestranol: Clinical aspects and laboratory tests
41. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis
42. Changes in concentrations of cortisol, dehydroepiandrosterone sulphate and progesterone in fetal and maternal serum during pregnancy
43. Study of plasma androgens in women with autoimmune diseases
44. Similar response of adrenocorticotrophic hormone, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis
45. Treatment of rheumatoid arthritis with the dopamine agonist quinagolide
46. Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: Demonstrated by a novel one-way MLC measuring cytokine secretion
47. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period?
48. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis
49. Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis
50. Pregnancy and the place of therapeutic abortion in rheumatoid arthritis
51. Effects of bromocriptine in patients with active rheumatoid arthritis
52. Rheumatoid arthritis. 1. Clinical effects of testosterone and pregnenolone therapy
53. Proceedings: A re-examination of the hypoglycaemia-induced 'stress' response of the hypothalamo-pituitary-adrenal axis in patients with rheumatoid arthritis on long-term adrenocorticotrophin (ACTH) therapy
54. Desmopressin and low-dose ACTH test in rheumatoid arthritis
55. Teratogenic potential of corticosteroids in humans
56. Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis
57. 17 Beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
58. Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis
59. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids
60. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation
61. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis
62. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion
63. Oral contraceptives and rheumatoid arthritis: New data from the Royal College of General Practitioners' oral contraception study
64. Circadian variation in disease activity in rheumatoid arthritis
65. Pregnancy and its effect on the risk of developing rheumatoid arthritis
66. Influence of oral contraception on the occurrence of rheumatoid arthritis in female sibs
67. Oral contraceptive treatment for rheumatoid arthritis: An open study in 10 female patients
68. Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives
69. Low blood and synovial fluid levels of sulphoconjugated steroids in rheumatoid arthritis
70. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis
71. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis
72. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, and intermittent hydroarthrosis
73. Corticosteroids in rheumatoid arthritis
74. Studies on adrenal cortical activity in patients with rheumatoid arthritis
75. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
76. Fractures after rheumatoid arthritis. A population-based study
77. Incidence of postpartum onset of disease among patients with rheumatoid arthritis
78. Prediction of postpartum onset of rheumatoid arthritis
79. The effect of certain steroid compounds on various manifestations of rheumatoid arthritis
80. The hypothesized hormonal control of mammalian sex ratio at birth - A second update
81. Sex ratios and hormones in HLA related rheumatic diseases
82. Prolactin in primary fibromyalgia and rheumatoid arthritis
83. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis
84. Kinetics of prolactin release in rheumatoid arthritis
85. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis
86. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle
87. ACTH, glucocorticoid and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation
88. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
89. Rheumatoid arthritis and pregnancy
90. Non-contraceptive hormones and the risk of rheumatoid arthritis in menopausal women
91. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis
92. Case-control study of rheumatoid arthritis and prior use of oral contraceptives
93. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality
94. Bromocriptine for refractory rheumatoid arthritis
95. The maternal hypothalamic-pituitaryadrenal axis in the third trimester of human pregnancy
96. Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: An odyssey of hormonal relationships to the disease
97. Incidence of rheumatoid arthritis: Do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis?
98. Sex hormones and rheumatoid arthritis: Cause or effect relationships in a complex pathophysiology?
99. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems
100. Prolactin in rheumatoid arthritis
101. High serum prolactin levels in men with rheumatoid arthritis
102. Free plasma testosterone levels during the normal menstrual cycle
103. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis
104. Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis
105. Regulation of TNF-alpha production in activated mouse macrophages by progesterone
106. A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity
107. Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis
108. Pregnancy in rheumatoid arthritis and systemic lupus erythematosus
109. The relationship of oral contraceptive use to rheumatoid arthritis
110. Long term effects of a first pregnancy on the hormonal environment: Estrogens and androgens
111. Prolactin deficiency in rheumatoid arthritis
112. Adrenal secretion of cortisol in patients with rheumatoid arthritis
113. Activity of rheumatoid arthritis during pregnancy
114. Pregnancy and rheumatoid arthritis
115. Fecundity before disease onset in women with rheumatoid arthritis
116. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis
117. Elevated free cortisol index in pregnancy: Possible regulatory mechanisms
118. Effect of pregnancy on the onset and course of rheumatoid arthritis
119. Hormones, pregnancy, and rheumatoid arthritis
120. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis
121. The secretion rate of cortisol in patients with rheumatoid arthritis
122. Dissociation of adrenal androgen and cortisol levels in acute stress
123. The transfer of drugs and other chemicals into human breast milk
124. The physiological disposition and metabolic fate of hydrocortisone in man
125. The lack of associations between rheumatoid arthritis and both nulliparity and infertility
126. An examination of the role of female hormones and pregnancy as risk factors for rheumatoid arthritis, using a male population as control group
127. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women
128. Testosterone, androstenedione and dehydroepiandrosterone in plasma during pregnancy and at delivery: Concentration and protein binding
129. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
130. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis
131. Evidence for reduced Th1 function in normal pregnancy: A hypothesis for the remission of rheumatoid arthritis
132. Postmenopausal bone loss in rheumatoid arthritis: Effect of estrogens and androgens
133. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis
134. The lysine-vasopressin test: An evaluation of two methods of administration in non-corticosteroid-treated and corticosteroidtreated patients with rheumatoid arthritis
135. Timing of pregnancy in relation to the onset of rheumatoid arthritis
136. Parity status and the development of rheumatoid arthritis
137. Pregnancy and rheumatoid arthritis
138. The pill, parity, and rheumatoid arthritis
139. Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls
140. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
141. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells
142. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis
143. Disease activity and pregnancy associated alpha 2-glycoprotein in rheumatoid arthritis during pregnancy
144. Hormonal pattern in women affected by rheumatoid arthritis
145. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis
146. Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis
147. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women
148. Oral contraceptives and rheumatoid arthritis: Further evidence for a preventive effect
149. The effects of morphine and nalorphine on the plasma 11-hydroxycorticosteroid response to insulin-induced hypoglycaemia in patients with rheumatoid arthritis
150. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?
151. Corticosterone metabolism and rheumatoid arthritis
152. The influence of sex on the phenotype of rheumatoid arthritis
153. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis
154. Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?
155. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study
156. The probability that increased secretion of oxysteroids does not fully explain improvement in certain systemic disease during pregnancy